Kendra Salazar, PA
Physician Assistant · Sugar Land, TXNPI 1770796872
Payments from drug & device makers
Across 1,253 payments — averaging $63.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$40K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$9K
- Incyte Corporation$4K
- Dermavant Sciences, Inc.$3K
- Verrica Pharmaceuticals Inc.$2K
- AbbVie$2K
- plus $19K from 25 others
What the payments were for
- Consulting fees$9,14211%
- Speaking & faculty fees$41,93053%
- Travel & lodging$3,3984%
- Food & beverage$24,65931%
- Education$6391%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 131 | $40,134 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 52 | $9,235 |
| Incyte Corporation | 51 | $3,589 |
| Dermavant Sciences, Inc. | 77 | $2,903 |
| Verrica Pharmaceuticals Inc. | 16 | $2,486 |
| AbbVie(2 entities) | 139 | $2,476 |
| Novartis | 91 | $1,816 |
| Johnson & Johnson | 76 | $1,665 |
| Regeneron Healthcare Solutions, Inc. | 50 | $1,544 |
| Sun Pharmaceutical Industries Inc. | 60 | $1,539 |
| E.r. Squibb & Sons, L.L.C. | 50 | $1,505 |
| Arcutis Biotherapeutics, Inc. | 89 | $1,294 |
| Organon | 24 | $1,287 |
| LEO Pharma Inc. | 54 | $1,263 |
| Mayne Pharma Commercial LLC | 50 | $1,209 |
| Amgen | 49 | $1,063 |
| Almirall LLC | 41 | $816 |
| Lilly USA, LLC | 33 | $689 |
| Sanofi | 25 | $633 |
| Journey Medical Corporation | 17 | $505 |
| Pfizer | 19 | $501 |
| EPI Health, LLC | 13 | $424 |
| UCB, Inc. | 14 | $371 |
| VYNE Pharmaceuticals Inc. | 21 | $364 |
| Medimetriks Pharmaceuticals, Inc. | 2 | $256 |
| Glenmark Therapeutics Inc. | 3 | $66 |
| ANI Pharmaceuticals, Inc. | 2 | $52 |
| Boehringer Ingelheim | 1 | $25 |
| Nabriva Therapeutics, PLC | 1 | $24 |
| Mission Pharmacal Company | 1 | $18 |
| Botanix SB Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$79,768 in reported general payments places this provider in the 95th percentile of 8,308 physician assistant providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 40 | $2,443 |
| Ketoconazole | 121 | $1,890 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 40 | $1,618 |
| Fluorouracil | 26 | $1,460 |
| Clindamycin Phosphate | 28 | $1,439 |
| Desonide | 24 | $1,290 |
| Metronidazole | 15 | $881 |
| Triamcinolone Acetonide | 92 | $835 |
| Doxycycline Hyclate | 14 | $768 |
| Mupirocin | 82 | $746 |
| CiclopiroxCiclopirox Olamine | 13 | $544 |
| Ciclopirox | 18 | $498 |
| Fluocinonide | 11 | $366 |
| Levocetirizine Dihydrochloride | 11 | $138 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Sugar Land
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Anthony DerenciusSan Antonio$507K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.